Chelsea Counsel Company’s Gilead Sciences GILD Stock Holding History

Chelsea Counsel Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$506	Hold	4	–	–	﹤0.01%	217
2026 Q1	$558	Hold	4	–	–	﹤0.01%	224
2025 Q4	$491	Hold	4	–	–	﹤0.01%	231
2025 Q3	$444	Buy	+4	New	+$455	﹤0.01%	235
2017 Q1	–	Sell	-3,994	Closed	-$286K	–	84
2016 Q4	$286K	Sell	3,994 -254	-6%	-$18.9K	0.15%	78
2016 Q3	$336K	Sell	4,248 -146	-3%	-$11.9K	0.17%	74
2016 Q2	$367K	Hold	4,394	–	–	0.17%	77
2016 Q1	$404K	Hold	4,394	–	–	0.13%	86
2015 Q4	$445K	Sell	4,394 -4,400	-50%	-$458K	0.13%	82
2015 Q3	$863K	Buy	8,794 +2,600	+42%	+$289K	0.21%	62
2015 Q2	$725K	Buy	6,194 +300	+5%	+$32.8K	0.16%	69
2015 Q1	$578K	Buy	5,894 +500	+9%	+$50.8K	0.12%	75
2014 Q4	$508K	Sell	5,394 -200	-4%	-$20.7K	0.1%	82
2014 Q3	$595K	Buy	5,594 +1,500	+37%	+$147K	0.12%	76
2014 Q2	$339K	Sell	4,094 -200	-5%	-$15.6K	0.07%	99
2014 Q1	$304K	Sell	4,294 -1,000	-19%	-$78.4K	0.06%	102
2013 Q4	$398K	Buy	+5,294	New	+$369K	0.09%	74

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Chelsea Counsel Company's GILD Position: Q2 2026 in Review

Chelsea Counsel Company held its Gilead Sciences (GILD) position steady in Q2 2026 at 4 shares worth $506. The position accounts for ﹤0.01% of the portfolio, ranked #217.

Chelsea Counsel Company first reported a position in GILD in Q4 2013 and has held it in 17 quarters since. The position peaked at $863K in Q3 2015. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Chelsea Counsel Company held 4 shares of Gilead Sciences worth $506 as of Q2 2026.
Chelsea Counsel Company left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up ﹤0.01% of Chelsea Counsel Company's portfolio in Q2 2026, its #217 holding.
Chelsea Counsel Company first reported a position in Gilead Sciences in Q4 2013 and has held it in 17 quarters since.
Chelsea Counsel Company's Gilead Sciences position peaked at $863K in Q3 2015.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Chelsea Counsel Company's 13F filing for Q2 2026, filed 12 Aug 2026.